Final Prostate Ablation Guidance Asks For More Safety Data
Executive Summary
Manufacturers developing devices to remove tissue in the prostate should provide the US FDA with follow-up information on patients that include certain indirect data about the long-term safety outcomes of using their product, according to a final agency guidance.